Bell's palsy and autoimmunity

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 323-328

  Greco, A ^a   Gallo, A ^a   Fusconi, M ^a   Marinelli, C ^a   Macri, G F ^a   de Vincentiis, M ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Aetiology; Autoimmunity; Bell's palsy; Pathogenesis; Therapy

Indexed keywords

ACICLOVIR; MYELIN; PREDNISONE; VALACICLOVIR;

AUTOIMMUNITY; BELL PALSY; DEMYELINATION; GUILLAIN BARRE SYNDROME; HERPES SIMPLEX; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; INCIDENCE; MONOTHERAPY; NEURITIS; PATHOGENESIS; PERIPHERAL PARALYSIS; REVIEW; SYSTEMATIC REVIEW;

AUTOIMMUNITY; BELL PALSY; HUMANS;

EID: 84870242347     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.05.008     Document Type: Review

References (82)

1. Gilden D.H. Clinical practice. Bell's palsy. N Engl J Med 2004, 351:1323-1331.
2. Kawiak W., Dudkowska A., Adach B. Diagnostic difficulties in etiology of the lesion of peripheral neuron of the facial nerve during the growth from of sialoma. Ann Univ Mariae Curie Sklodowska Med 1993, 8:125-128.
3. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002, 549:4-30.
4. Wolf S.R. Idiopathic facial paralysis. HNO 1998, 46:786-798.
5. Adour K.K., Byl F.M., Hilsinger R.L., Kahn Z.M., Sheldon M.I. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978, 88:787-801.
6. Morris A.M., Deeks S.L., Hill M.D., Midroni G., Goldstein W.C., Mazzulli T., et al. Annualized incidence and spectrum of illness an outbreak investigation of Bell's palsy. Neuroepidemiology 2002, 21:255-261.
7. Prescott C.A. Idiopathic facial nerve palsy (the effect of treatment with steroids). J Laryngol Otol 1988, 102:403-407.
8. Katusic S.K., Beard C.M., Wiederholt W.C., Bergstralh E.J., Kurland L.T. Incidence, clinical features, and prognosis in Bell's palsy. Rochester, the Minnesota 1968-1982. Ann Neurol 1986, 20:622-627.
9. Holland N.J., Weiner G.M. Recent developments in Bell's palsy. Br Med J 2004, 329:553-557.
10. Karens W.E. Diseases of seventh cranial nerve. Pheripheral neuropathy 1993, 818-836. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Podulso (Eds.).
11. Ahmed A. When is facial paralysis Bell palsy? Current diagnosis and treatment. Cleve Clin J Med 2005, 72:398-401.
12. Pitts D.B., Adour K.K., Hilsinger R.L. Recurrent Bell's palsy: analysis of 140 patients. Laryngoscope 1988, 98:535-540.
13. Sartoretti-Schefer S., Wichmann W., Valavanis A. Idiopathic, herpetic, and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. Am J Neuroradiol 1994, 15:479-485.
14. Liston S.L., Kleid M.S. Histopathology of Bell's palsy. Laryngoscope 1989, 99:23-26.
15. Clark J.R., Carlson R.D., Sasaki C.T. Facial paralysis in Lyme disease. Laryngoscope 1985, 95:1341-1345.
16. Atzema C., Goldman R.D. Should we use steroids to treat children with Bell's palsy?. Can Fam Physician 2006, 52:313-314.
17. Mc Cormick D.P. Herpes simplex virus as a cause of Bell's palsy. Lancet 1972, 1:937.
18. Leibowitz U. Epidemic incidence of Bell's palsy. Brain 1969, 92:109-114.
19. Kynvett A.F. Viral infection of the nervous system. Med J Aust 1959, 2:118-121.
20. Schwaber M.K., Larson T.C., Zealer D.L., Creasy J. Gadolinium-enhanced magnetic resonance imaging in Bell's palsy. Laryngoscope 1990, 100:1264-1269.
21. Traavik T., Storvold G., Sundsfjord A., Lund S., Mair I.W. Peripheral facial palsy and coincidental cytomegalovirus infection or reactivation. Scand J Infect Dis 1983, 15:233-238.
22. Grose C., Feorino P.M., Dye L.A., Rand J. Bell's palsy and infectious mononucleosis. Lancet 1973, 2:231-232.
23. Njoo F.L., Werthheim-van Dillen P., Devriese P.P. Serology in facial paralysis caused by clinically presumed herpes zoster infection. Arch Otolaryngol 1988, 245:230-237.
24. Jamal G.A., Al Husaini A. Bell's palsy and infection with rubella virus. J Neurol Neurosurg Psychiatry 1983, 46:678-680.
25. Brown M.M., Thompson A., Goh B.T., Forster G.E., Swash M. Bell's palsy and HIV infection. J Neurol Neurosurg Psychiatry 1988, 51:425-426.
26. Morgan M., Nathwani D. Facial palsy and infection. The unfolding story. Clin Infect Dis 1992, 14:263-271.
27. Smouha E.E., Coyle P.K., Skukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol 1997, 18:257-261.
28. Hunt J.R. On herpetic inflammation of the geniculate ganglion. A new syndrome and its complications. J Nerv Ment Dis 1907, 34:73-96.
29. Aitkin R.S., Brain R.T. Facial palsy and infectious zoster virus. Lancet 1933, 1:19-22.
30. Ravin L.C. Facial paralysis as a complication of chicken-pox. Am J Ophthalmol 1961, 52:723-724.
31. Peitersen E., Caunt A.E. The incidence of herpes zoster antibodies in patients with peripheral facial palsy. J Laryngol 1970, 84:65-70.
32. Tomita H., Hayakawa W., Hondo R. Varicella-zoster virus in idiopathic facial palsy. Arch Otolaryngol 1972, 95:364-368.
33. Steiner I. Human herpes viruses latent infection in the nervous system. Immunol Rev 1996, 152:157-173.
34. Goodpasture E.W. Herpetic infections with special reference to involvement of the nervous system. Medicine 1929, 8:223-243.
35. Hope-Simpson R.E. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 1965, 58:9-20.
36. Tomita H., Tanaka M., Kukimoto N., Ikeda M. An ELISA study on Varicella-zoster virus infection in acute peripheral facial palsy. Acta Otolaryngol 1988, 446:S6-S10.
37. Morgan M., Moffat M., Ritchie L., Collacott I., Braun T. Is Bell's palsy a reactivation of Varicella zoster virus ?. J Infect 1995, 30:29-36.
38. Murakami S., Honda N., Mizobuchi M., Nakashiro Y., Hato N., Gyo K. Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology 1998, 51:1202-1205.
39. Terada K., Niizuma T., Kawano S., Kataoka N., Akisada T., Orita Y. Detection of Varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsey Hunt syndrome or zoster sine herpete. J Med Virol 1998, 56:359-363.
40. Gilden D.H., Dueland A.N., Devlin M.E., Mahalingam R., Cohrs R. Varicella-zoster virus reactivation without rash. J Infect Dis 1992, 166(Suppl. 1):S30-S34.
41. Takasu T., Furuta Y., Sato K.C., Fukuda S., Inuyama Y., Nagashima K. Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol 1992, 112:1004-1011.
42. Schulz P., Arbusow V., Strupp M., Dieterich M., Rauch E., Brandt T. Highly variable distribution of HSV-1 specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 1998, 252:139-142.
43. Murakami S., Mizobuchi M., Nakashiro Y., Doi T., Hato N., Yanagihara N. Bell's palsy and herpes simplex: identification of viral DNA in endoneural fluids and muscle. Ann Intern Med 1996, 127:27-30.
44. Dobson A.T., Margolis T.P., Sedarati F., Stevebs J.G., Feldman L.T. A latent, nonpathogenic HSV-1 derived vector stably expresses beta galactosidase in mouse neurons. Neuron 1990, 5:353-360.
45. Steiner I., Spivack J.G., O'Boyle D.R., Lavi E., Fraser N.W. Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J Virol 1988, 62:3493-3496.
46. Whitley R.I. Epidemiology of herpes simplex viruses. The herpes viruses 1985, vol. 3:1-44. Plenum Publishing, New York. B. Roizman (Ed.).
47. Abramsky O., Webb C., Teitelbaum D., Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell's palsy). J Neurol Sci 1975, 26:13-20.
48. Mc Govern F.H., Estevez J., Jackson R. Immunological concept for Bell's palsy: further experimental study. Ann Otol Rhinol Laryngol 1977, 86:300-305.
49. Mulkens P.S., Bleeker J.D., Schroeder F.P. Acute facial paralysis: a virological study. Clin Otolaryngol 1980, 5:303-309.
50. Aviel A., Ostfeld E., Burstein R., Marshak G., Bentwich Z. Peripheral blood T and B lymphocyte subpopulations in Bell's palsy. Ann Otol Rhinol Laryngol 1983, 92:187-191.
51. Mañós-Pujol M., Buendia E., Mestre M., Jimenéz R., Gil E., Menén J.P., et al. Cellular immunity abnormalities in patients with recurrent Bell's palsy. Clin Otolaryngol 1987, 12:283-287.
52. Gorodezky C., Carranza J.M., Bustamante A., et al. The HLA system and T-cell subsets in Bell's palsy. Acta Otolaryngol 1991, 111:1070-1074.
53. Charous D.I., Saxe B.I. The Landry Guillain Barré syndrome. Report of an unusual case, with a comment on Bell's palsy. N Engl J Med 1962, 267:1334-1338.
54. Abramsky O., Webb C., Teitelbaum D., Arnon R. Cell-mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Clinical-immunological classification of the nervous system autoimmune demyelinating disorders. Neurology 1975, 25:1154-1159.
55. Vedeler C., Nyland H., Matre R. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain Barré syndrome demonstrated by a mixed haemagglutination technique. J Neuroimmunol 1982, 2:209-214.
56. Vedeler C.A., Matre R., Nyland H., Moller P. Immunoglobulins, complement components and lymphocyte subpopulations in Bell's palsy. Eur Neurol 1986, 25:177-182.
57. Nyland H., Naess A. Lymphocytes subpopulations in blood and cerebrospinal fluid from patients with acute Guillain-Barré syndrome. Eur Neurol 1978, 17:247-252.
58. Hughes R., Aslan S., Gray I. Lymphocytes subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome). Clin Exp Immunol 1983, 51:448-454.
59. Lisak R.P., levinson A.I., Zweiman B., Abdou N.I. T and B lymphocytes in multiple sclerosis. Clin Exp Immunol 1975, 22:30-34.
60. Chaco J. Subclinical pheripheral nerve involvement in unilateral Bell's palsy. Am J Phys Med 1973, 52:195-197.
61. Weiner L.P., Johnson R.T., Herndon R.M. Viral infections and demyelinating diseases. N Engl J Med 1973, 288:1103-1109.
62. Lampert P.W. Autoimmune and virus induced demyelinating diseases. Am J Pathol 1978, 91:176-208.
63. Mc Govern F.H., Estevez J. The concept of Bell's palsy as an immunologically mediated disease. Proceedings of the Shambaugh Fifth International Workshop on Middle Ear Microsurgery and Fluctuant Hearing Loss 1976, 229-232. The Strode Publishers, Huntsville, Ala. G.E. Shambaugh, J.J. Shea (Eds.).
64. Yilmaz M., Tarakcioglu M., Bayazit N., Bayazit Y.A., Namiduru M., Kanlikama M. Serum cytokine levels in Bell's palsy. J Neurol Sci 2002, 197:69-72.
65. Hoare M., Woodall T., Alexander G.J. Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res 2005, 25:174-176.
66. Maning J.J., Adour K.K. Facial paralysis in children. Pediatrics 1972, 49:102-109.
67. Martin G.I., Weintraub M.I. Brachial neuritis and seventh nerve palsy. A rare hazard of DPT vaccination. Clin Pediatr 1973, 12:506-507.
68. Mc Neela E.A., Mills K.H.G. Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev 2001, 51:43-54.
69. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350:896-903.
70. Adour K.K., Wingerd J. Idiopathic facial paralysis (Bell's palsy): factors affecting severity and outcome in 446 patients. Neurology 1974, 24:1112-1116.
71. Adour K.K., Wingerd J., Bell D.N., Maning J.J., Hurley J.P. Prednisone treatment for idiopathic facial paralysis (Bell's palsy). N Engl J Med 1972, 287:1268-1272.
72. Gabrielsen A.E., Good R.A. Chemical suppression of adaptive immunity. Adv Immunol 1967, 6:91-229.
73. Williamson I.G., Whelan T.R. The clinical problem of Bell's palsy: is treatment with steroids effective?. Br J Gen Pract 1996, 46:743-747.
74. De Diego J.I., Prim M.P., De Sarria M.J., Madero R., Gavilan J. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single dose prednisone versus acyclovir three times daily. Laryngoscope 1998, 108:573-575.
75. Allen D., Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2004, (3):CD001869.
76. Hato N., Yamada H., Kohno H., Matsumoto S., Honda N., Gyo K., et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007, 28:408-413.
77. Kieseier B.C., Lehmann H.C., Horste G.M. Autoimmune diseases of the peripheral nervous system. Autoimmun Rev 2012, 11:191-195.
78. Selmi C., Mix E., Zettl U.K. A clear look at the neuroimmunology of multiple sclerosis and beyond. Autoimmun Rev 2012, 11:159-162.
79. Kamm C., Zettl U.K. Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev 2012, 11:196-202.
80. Grogan P.M., Gronseth G.S. Practice parameter: steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:830-836.
81. Bulstrode N.W., Harrison D.H. The phenomenon of the late recovered Bell's palsy: treatment options to improve facial symmetry. Plast Reconstr Surg 2005, 115:1466-1471.
82. Hughes G.B., Barna B.P., Kinney S.E., Goren H., Sweeney P.J., Valenzuela R., et al. Immune reactivity in Bell's palsy. Otolaryngol Head Neck Surg 1986, 95:586-588.